Physician profile
Clara Ji Chae
NPI 1861697427
$2,807.94
in general payments reported to CMS, 2019-2025
29 companies · $402 in 2025
The $402 reported for 2025 was more than what a typical Obstetrics provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $766 · 2020: $160 · 2021: $44.44 · 2022: $582 · 2023: $460 · 2024: $394 · 2025: $402.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,255.83 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $907.39 | 2019-2022 | |
| Avanos Medical | $419.52 | 2019-2023 | On-Q* Pump and Accessories |
| Glaxosmithkline, LLC. | $246.68 | 2024 | Jemperli |
| Alexion Pharmaceuticals, INC. | $126.79 | 2023 | |
| Aspira Women'S Health INC | $101.32 | 2022-2023 | Ova1 |
| Biogen, INC. | $100.36 | 2025 | Zurzuvae |
| Janssen Biotech, INC. | $100.14 | 2023-2025 | Stelara, Simponi, Simponi Aria |
| Femselect INC. | $88.45 | 2023 | Enplace |
| Pfizer INC. | $75.41 | 2021-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $69.61 | 2024-2025 | Entyvio |
| Baxter Healthcare | $67.29 | 2019-2021 | |
| Abbvie INC. | $56.88 | 2019-2025 | |
| Exact Sciences Corporation | $44.02 | 2024-2025 | Cologuard Collection Kit |
| Abbott Laboratories | $43.53 | 2025 | Freestyle Libre 3 |
| Boston Scientific Corporation | $42.55 | 2025 | Wavewriter Alpha Prime 16 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $35.63 | 2023 | Interstim |
| Coopersurgical, INC. | $33.69 | 2020-2023 | Paragard T 380a |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.81 | 2024 | Lifevest |
| Irhythm Technologies, INC. | $27.32 | 2023 | Zio Xt Patch |
| Ethicon US, LLC | $26.23 | 2022 | |
| Merck Sharp & Dohme LLC | $24.71 | 2025 | Gardasil 9, Capvaxive |
| Hologic Sales and Service, LLC | $22.00 | 2025 | Myosure Tissue Removal Device |
| Bayer Healthcare Pharmaceuticals INC. | $20.70 | 2023 | |
| Astellas Pharma US INC | $19.81 | 2023 | Veozah |
| Sumitomo Pharma America, INC. | $16.91 | 2025 | Myfembree |
| Amag Pharmaceuticals, INC. | $16.46 | 2019 | |
| Organon LLC | $15.55 | 2023 | Nexplanon |
| Redhill Biopharma INC. | $15.27 | 2023 | Talicia |
| Mayne Pharma Commercial LLC | $11.91 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Clara Chae listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.